CytoMed Therapeutics (GDTC) Short term Debt (2021 - 2025)
CytoMed Therapeutics (GDTC) posted Short term Debt of $31516.6 for Q4 2025, up 11.35% sequentially from $28304.4 in Q4 2024, and up 11.35% YoY from $28304.4 in Q4 2024.
CytoMed Therapeutics (GDTC) Short term Debt (2021 - 2025) Analysis & Trends
CytoMed Therapeutics has reported Short term Debt for 5 years, with the latest figure at $31516.6 in Q4 2025.
- Quarterly Short term Debt rose 11.35% year-over-year to $31516.6 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $31516.6 (up 11.35% YoY) and the FY2025 annual result came in at $31765.0, up 15.27% from the prior year.
- Short term Debt grew to $31516.6 in Q4 2025 per GDTC's latest filing, from $28304.4 in the prior quarter.
- Over five years, Short term Debt peaked at $284211.5 in Q4 2021 and troughed at $9693.0 in Q2 2024.
- A 5-year average of $90074.9 and a median of $28304.4 in 2024 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2023 and 2024: Short term Debt plunged 89.58% in 2023, then advanced 12.64% in 2024.
- Over 5 years, Short term Debt stood at $284211.5 in 2021, then fell by 15.12% to $241229.0 in 2022, then slumped by 89.58% to $25128.7 in 2023, then increased by 12.64% to $28304.4 in 2024, then grew by 11.35% to $31516.6 in 2025.
- According to Business Quant data, Short term Debt over the past three periods registered $31516.6, $28304.4, and $9693.0 for Q4 2025, Q4 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CytoMed Therapeutics | 10.72 Mn | 9.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31,516.65 |
| Dec 31, 2024 | 28,304.38 |
| Jun 30, 2024 | 9,693.00 |
| Dec 31, 2023 | 25,128.73 |
| Jun 30, 2023 | 10,441.00 |
| Dec 31, 2022 | 241,229.01 |
| Dec 31, 2021 | 284,211.45 |